Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel immunosuppressive agents in tolerance induction.

N R Krieger1, S J Knechtle

  • 1Division of Organ Transplantation, Department of Surgery, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA.

Current Drug Targets. Cardiovascular & Haematological Disorders
|May 29, 2003
PubMed
Summary

Achieving transplantation tolerance aims to free patients from long-term immunosuppression. Current strategies involve limited immunosuppressive agent use, with promising preliminary data from embryonic stem cells for tolerance induction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Expanding the Donor Pool With Normothermic Ex Vivo Liver Perfusion: The Future Is Now.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Regulating T Cell Behavior.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Surgical technique in transplantation: how much does it matter?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Regenerative Medicine

Background:

  • Induction of transplantation tolerance is a key goal to eliminate lifelong immunosuppression.
  • Current tolerance induction strategies rely on temporary immunosuppressive drug administration.
  • Novel agents and approaches are continuously being explored to improve outcomes.

Purpose of the Study:

  • To review current agents and strategies for inducing transplantation tolerance.
  • To explore the potential of embryonic stem cells in enhancing tolerance induction.
  • To assess the progress and feasibility of clinical transplantation tolerance.

Main Methods:

  • Review of existing literature on immunosuppressive agents for tolerance induction.
  • Categorization of agents into lymphocyte depletion, costimulation blockade, and adjunctive therapies (e.g., rapamycin).

Related Experiment Videos

  • Examination of preliminary data on donor stem cells, including embryonic stem cells, for tolerance induction.

    • Main Results:

    • Various agents, including those targeting lymphocyte depletion and costimulation blockade, are employed.
    • Rapamycin is noted as an adjunctive agent in tolerance induction protocols.
    • Preliminary findings suggest embryonic stem cells may offer advantages over conventional bone marrow for tolerance induction.

    Conclusions:

    • Successful induction of transplantation tolerance can potentially free patients from long-term immunosuppression.
    • Progress in clinical tolerance induction is evident, with achievable results in a subset of patients.
    • Embryonic stem cells show promise as a superior alternative for future tolerance induction strategies.